What conditions are associated with elevated Creatine Kinase (CK) MB levels?

Conditions Associated with Elevated CK-MB Levels

Elevated Creatine Kinase MB (CK-MB) levels can occur in various cardiac and non-cardiac conditions, with cardiac troponins now being the preferred biomarker for myocardial injury due to their superior specificity and sensitivity. 1, 2

Cardiac Causes of Elevated CK-MB

• Acute Myocardial Infarction (AMI): CK-MB rises 3-4 hours after myocardial injury, peaks at 24 hours, and returns to normal within 2-3 days 1, 2
• Myocarditis: Inflammation of the heart muscle can cause CK-MB elevation 3
• Cardiac contusion: Traumatic injury to the heart can release CK-MB 3
• Cardiac procedures: Including surgery, ablation, pacing, or defibrillator shocks 3
• Stress cardiomyopathy: Also known as Takotsubo cardiomyopathy 3
• Cardiotoxic agents: Certain medications or substances that damage cardiac tissue 3
• Microinfarction: Small areas of myocardial necrosis that may not elevate total CK but can elevate CK-MB percentage 4
• Three-vessel coronary disease: Associated with higher relative CK-MB values during AMI 5

Non-Cardiac Causes of Elevated CK-MB

• Skeletal muscle trauma: CK-MB is not completely cardiac-specific and can be released from damaged skeletal muscle 1, 6, 3
• Strenuous exercise: Particularly activities involving eccentric muscle contractions 3
• Muscular dystrophies: Especially Duchenne's muscular dystrophy 3
• Glycogen storage diseases: Such as Pompe disease 3
• Rhabdomyolysis: Severe muscle breakdown can cause significant CK-MB elevation 7
• Stroke: CK-MB can be elevated after large hemispheric infarctions, though this is not cardiac in origin as demonstrated by normal troponin T levels in these patients 8
• Chronic renal failure: Can cause elevated cardiac biomarkers including CK-MB 9

Clinical Significance and Interpretation

• CK-MB has been largely replaced by cardiac troponins for diagnosing myocardial injury due to troponins' superior cardiac specificity 1, 2

• CK-MB remains useful in specific situations:

  • Reinfarction diagnosis: Due to its shorter half-life compared to troponin, making it valuable when evaluating for recurrent infarction within 1-2 weeks of initial MI 2, 10
  • Periprocedural myocardial injury: During cardiac interventions where the diagnostic value has been extensively validated 10

• The CK-MB index (ratio of CK-MB to total CK) helps differentiate cardiac from skeletal muscle sources:

  • Index >5.0 is diagnostic of myocardial infarction
  • Index <3.0 virtually excludes myocardial infarction
  • Index >3.0 in a single test makes rhabdomyolysis improbable 7

Important Considerations

• A rising and/or falling pattern of CK-MB is needed to distinguish acute from chronic elevations 3
• Patients with normal total CK but elevated CK-MB percentage may have clinically significant "microinfarctions" associated with worse outcomes 4, 11
• Pre-infarction beta-blocker treatment may result in lower relative CK-MB levels during AMI 5
• Measurement of total CK alone is not recommended for diagnosis of myocardial infarction due to its large skeletal muscle distribution and lack of specificity 9
• When assessing CK-MB, mass immunoassays should be used rather than older methods, and sex-specific reference values should be employed 10, 3

Current Recommendations

• Troponin T or I should be measured on admission and, if normal, repeated 6-12 hours later when myocardial injury is suspected 2
• CK-MB should be reserved for specific situations such as reinfarction diagnosis or periprocedural myocardial injury evaluation 10
• For suspected skeletal muscle versus cardiac source, the CK-MB index provides valuable diagnostic information 7